URINARY C PEPTIDE/ CREATININE RATIO AND ITS RELATION TO INSULIN RESISTANCE AND VASCULAR COMPLICATIONS IN TYPE 2 DIABETES | ||||
| ALEXMED ePosters | ||||
| Article 1, Volume 7, Issue 1, January 2025, Page 8-9 | ||||
| Document Type: Preliminary preprint short reports of original research | ||||
| DOI: 10.21608/alexpo.2025.352132.2063 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Eman Youssef Morsy1; Noha Amin2; Heba Sadek Kassab3; Rowan Khalifa Ali Khalifa Mostafa  1
| ||||
| 1Department of Internal Medicine Diabetes and Metabolism, Faculty of Medicine, Alexandria University | ||||
| 2Department of Internal Medicine, Faculty of Medicine, Alexandria University | ||||
| 3Department of Internal Medicine, Faculty of Medicine, Alexandria University, Egypt | ||||
| Abstract | ||||
| INTRODUCTION: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance (IR) which leads overtime to hyperglycemia and progressive beta cell dysfunction. IR is a potent risk factor for vascular complications of diabetes including macro and microvascular complications, which contribute significantly to morbidity and mortality. Urinary c peptide, a byproduct of insulin secretion, serves as a reliable biomarker for beta cell function due to its stability in urine and it is easy to collect. When normalized to creatine levels, the urinary c peptide creatinine ratio (UCPCR) provides a simple, noninvasive measure of endogenous insulin secretion. Close correlations between serum C-peptide, and UCPCR have been shown. And since, high serum C-peptide concentration is a strong indicator of metabolic syndrome and IR, this suggests that UCPCR could be a promising marker for assessing IR. AIM OF THE WORK: The aim of the present study was to assess urinary c peptide /creatinine ratio in patients with T2DM and its relation to insulin resistance and vascular complications. | ||||
| Keywords | ||||
| UCPCR; IR; T2DM | ||||
|
Supplementary Files
|
||||
|
Statistics Article View: 74 |
||||
